Literature DB >> 27915422

State of the Art Review of the Right Ventricle in COPD Patients: It is Time to Look Closer.

Daniela Graner Schuwartz Tannus-Silva1, Marcelo Fouad Rabahi2.   

Abstract

Since the first description of pulmonary circulation in the 16th century, the knowledge of the complex interaction between the heart and lungs has greatly improved. Hypoxemia plays a classical role in the development of complications such as pulmonary hypertension and right ventricle (RV) dysfunction in patients presenting with chronic obstructive pulmonary disease (COPD). However, more recent results have revealed the presence of RV vascular structural and functional changes even in patients with mild COPD, without hypoxemia or pulmonary hypertension at rest. Compared to the left ventricle, the anatomy of the RV is unique and complex, which makes its assessment more difficult during routine exams. Therefore, it is common that very little attention is paid to its study. In this article, the physiological aspects of pulmonary circulation and the RV, as well as their impairment in COPD patients, are presented. In addition, important aspects of the recommendations for RV assessment using echocardiography are approached and studies that used other complementary exams to evaluate RV structure and function are revisited. Finally, the findings of studies that assessed the impact of RV dysfunction in the prognosis of patients with COPD are described.

Entities:  

Keywords:  COPD; Echocardiography; Right ventricle assessment; Right ventricle dysfunction

Mesh:

Year:  2016        PMID: 27915422     DOI: 10.1007/s00408-016-9961-5

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  59 in total

Review 1.  Multimodality Evaluation of the Right Ventricle: An Updated Review.

Authors:  Marijana Tadic
Journal:  Clin Cardiol       Date:  2015-08-20       Impact factor: 2.882

Review 2.  Right ventricular function in cardiovascular disease, part I: Anatomy, physiology, aging, and functional assessment of the right ventricle.

Authors:  François Haddad; Sharon A Hunt; David N Rosenthal; Daniel J Murphy
Journal:  Circulation       Date:  2008-03-18       Impact factor: 29.690

3.  Cor pulmonale revisited.

Authors:  Lewis J Rubin
Journal:  J Am Coll Cardiol       Date:  2013-07-10       Impact factor: 24.094

4.  Brain natriuretic peptide is a prognostic parameter in chronic lung disease.

Authors:  Hanno H Leuchte; Rainer A Baumgartner; Michal El Nounou; Michael Vogeser; Claus Neurohr; Michael Trautnitz; Juergen Behr
Journal:  Am J Respir Crit Care Med       Date:  2006-01-13       Impact factor: 21.405

5.  Systemic inflammation in patients with COPD and pulmonary hypertension.

Authors:  Pavol Joppa; Darina Petrasova; Branislav Stancak; Ruzena Tkacova
Journal:  Chest       Date:  2006-08       Impact factor: 9.410

6.  Right ventricular dysfunction and remodeling in chronic obstructive pulmonary disease without pulmonary hypertension.

Authors:  Janne Mykland Hilde; Ingunn Skjørten; Ole Jørgen Grøtta; Viggo Hansteen; Morten Nissen Melsom; Jonny Hisdal; Sjur Humerfelt; Kjetil Steine
Journal:  J Am Coll Cardiol       Date:  2013-07-10       Impact factor: 24.094

7.  Evaluation of right ventricular remodeling using cardiac magnetic resonance imaging in co-existent chronic obstructive pulmonary disease and obstructive sleep apnea.

Authors:  Bhavneesh Sharma; Tomas G Neilan; Raymond Y Kwong; Damien Mandry; Robert L Owens; David McSharry; Jessie P Bakker; Atul Malhotra
Journal:  COPD       Date:  2012-12-28       Impact factor: 2.409

8.  Assessment of the right ventricular function in patients with chronic obstructive pulmonary disease using MRI.

Authors:  Yan Gao; Xiangying Du; Wen Qin; Kuncheng Li
Journal:  Acta Radiol       Date:  2011-09-01       Impact factor: 1.990

Review 9.  Natriuretic peptides.

Authors:  Lori B Daniels; Alan S Maisel
Journal:  J Am Coll Cardiol       Date:  2007-12-18       Impact factor: 24.094

Review 10.  Systemic manifestations and comorbidities of COPD.

Authors:  P J Barnes; B R Celli
Journal:  Eur Respir J       Date:  2009-05       Impact factor: 16.671

View more
  5 in total

1.  Risk factors for right ventricular dysfunction in patients with lymphangioleiomyomatosis.

Authors:  Wei Hua; Wenbo Yang; Jianing Gu; Jialiang Wu; Wei Wang; Yanpu Liu; Hong Zhu; Min Zhou; Jieming Qu; Yuehua Fang
Journal:  Int J Cardiovasc Imaging       Date:  2020-09-14       Impact factor: 2.357

Review 2.  Lung function and cardiovascular disease: A link.

Authors:  Sergio H R Ramalho; Amil M Shah
Journal:  Trends Cardiovasc Med       Date:  2020-01-03       Impact factor: 6.677

3.  First in vivo assessment of RAS-Q technology as lung support device for pulmonary hypertension.

Authors:  Tom Verbelen; Michael Halwes; Bart Meyns
Journal:  Int J Artif Organs       Date:  2020-09-10       Impact factor: 1.595

4.  Left ventricular dysfunction in relation with systemic inflammation in chronic obstructive pulmonary disease patients.

Authors:  Sule Tas Gulen; Ufuk Eryilmaz; Mustafa Yilmaz; Fisun Karadag
Journal:  Korean J Intern Med       Date:  2018-10-29       Impact factor: 2.884

Review 5.  Cor pulmonale: the role of traditional and advanced echocardiography in the acute and chronic settings.

Authors:  Giulia Elena Mandoli; Carlotta Sciaccaluga; Francesco Bandera; Paolo Cameli; Roberta Esposito; Antonello D'Andrea; Vincenzo Evola; Regina Sorrentino; Alessandro Malagoli; Nicolò Sisti; Dan Nistor; Ciro Santoro; Elena Bargagli; Sergio Mondillo; Maurizio Galderisi; Matteo Cameli
Journal:  Heart Fail Rev       Date:  2021-03       Impact factor: 4.214

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.